Advisers could land $100 million payday from Actelion sale

LONDON, Jan 26 (Reuters) - Advisers could pocket up to $100

million in fees from Johnson & Johnson's $30 billion

acquisition of Swiss biotech firm Actelion, the largest

takeover of a European...

Read more